Spectrum Asset Management (California)’s VolitionRx Ltd VNRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,780
Closed -$42.1K 110
2024
Q1
$42.1K Hold
2,780
0.02% 96
2023
Q4
$39.9K Hold
2,780
0.02% 86
2023
Q3
$38.3K Hold
2,780
0.02% 89
2023
Q2
$77.3K Hold
2,780
0.04% 85
2023
Q1
$106K Hold
2,780
0.05% 85
2022
Q4
$135K Buy
+2,780
New +$108K 0.07% 94
2022
Q3
Sell
-2,780
Closed -$114K 94
2022
Q2
$114K Hold
2,780
0.06% 91
2022
Q1
$167K Hold
2,780
0.07% 110
2021
Q4
$175K Hold
2,780
0.05% 121
2021
Q3
$172K Hold
2,780
0.05% 114
2021
Q2
$183K Hold
2,780
0.05% 116
2021
Q1
$210K Buy
+2,780
New +$238K 0.06% 114

Other funds holding VNRX

Spectrum Asset Management (California)'s VNRX Position: Q2 2024 in Review

Spectrum Asset Management (California) sold out of VolitionRx Ltd (VNRX) in Q2 2024, closing a stake of 2,780 shares — an estimated $42.1K sold.

Spectrum Asset Management (California) first reported a position in VNRX in Q1 2021 and held it in 12 quarters. The position peaked at $210K in Q1 2021. 26 funds tracked by Wall St. Rank hold VNRX as of Q2 2024.

  • Spectrum Asset Management (California) reported no remaining VolitionRx Ltd position as of Q2 2024 after selling out during the quarter.
  • Spectrum Asset Management (California) sold 2,780 VolitionRx Ltd shares in Q2 2024, an estimated $42.1K.
  • Spectrum Asset Management (California) first reported a position in VolitionRx Ltd in Q1 2021 and held it in 12 quarters.
  • Spectrum Asset Management (California)'s VolitionRx Ltd position peaked at $210K in Q1 2021.
  • 26 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2024.

Based on Spectrum Asset Management (California)'s 13F filing for Q2 2024, filed 12 Jul 2024.